We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Medicsight | MDST | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.45 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.45 |
| Top Posts |
|---|
Posted at 23/8/2011 21:32 by a.fewbob New millenium resources (NML) delisted a couple of years ago in a similar manner. AIM washed their hands of them and all the investors, no fiancial reports have ever been issued, no expenation into the events leading up to the delist, no account of where the money went,No investigations, Nothing! Everyone concerned just decided to put it down to experience!!!!!!! I thought the whole point of markets like AIM was to prevent crooks from walking off with investors money, completely unaccountably. Clearly, those that work in the city are above the law. |
Posted at 22/8/2011 10:26 by happier Whos is buying? Must be smart investors. |
Posted at 08/6/2011 17:15 by cumnor Could suit both parties, eg provide a bit of liquidity ahead of announcement, deal etc. Nothing has changed and expect a flow of RNSs soon. They sold very little and could easily have offloaded an awful lot more after the FDA news at a higher price were that their intention so I see nothing in it. A growing company needs a wider shareholder base to be taken seriously by IIs before they invest and so it is in the interest of a very large shareholder to ensure no one in particular has complete control. Otherwise you deter serious investors who want in after good news which would then be expected to drive the share price higher and mgmt might prfer this. News of contracts or deals will drive this soon imo. Expect and would like to see a little more selling by them but it will be well orchestrated and timed. A positive for the share price |
Posted at 24/5/2011 16:02 by cumnor Small free float and i would be surprised to see any big investors wind down now the party has just begun, and some have gotten in at a pound plus. Hard to value but, with FDA backing in place, a 100ml dollar market cap at this early stage of a hightech/cancer diagnostic outfit's life would'nt be unusual in the States. Imo dyot |
Posted at 20/5/2011 09:48 by foret Just about averaging previous buysif 10pence is the bid butstarting to believe the hype after many years of being dissapointed by this prodigal son.. On a general level what do investors here think of the risk of buying at present levels... |
Posted at 19/5/2011 18:12 by crosswire Evening StandardFurther down the pecking order, medical imaging company Medicsight shot up 2.6p to 6p. American health watchdogs have given the green light to its technology which helps radiologists to look for abnormal tissue growth in patients' colons. But today's jump will only be a small comfort to long-term investors: the shares was changing hands for 25p at the start of 2009. |
Posted at 18/8/2009 16:26 by towpath2 well,where have you all gone?potential fellow investors are encouraged if you have something to say.Not like katie price of course.Good luck to you all. |
Posted at 27/11/2008 10:09 by ellands2 Sorry Moverman,I had to blame someone for the share price LOL.When the share price was doing ok,yourself and Fryern was always bulling the share up but when it started to go down you both disappeared which looked like you was both ramping the share.I contacted investor relations at MGT yesterday,and was quite happy with his reply.He stated the company was in good shape,no debt,$50m in cash,still waiting for clearances in USA and Japan for the CAD software and there was going to be a significant revenue ramp in 2009-2010.He just put the declining share price to the horrible market conditions in USA small to mid-cap stocks.You can contact him at-alex@medicsight.c |
Posted at 07/7/2007 06:26 by fryern July 06, 2007: 04:00 PM ESTLONDON, July 6 /PRNewswire-FirstCal Separately, the Company announced that Mr. Paterson-Brown is scheduled to "ring the opening bell" at the American Stock Exchange ("AMEX") on Monday, July 9, 2007 at 9:30 a.m. Eastern time. Also on hand for the bell ringing will be MGT CFO Allan Rowley. MGT Capital Investments joins the long list of AMEX-listed companies and dignitaries that have opened trading on the AMEX in a tradition that dates back to 1921. Tim Paterson-Brown, Chairman and CEO, stated, "MGT has made significant progress in the year and half we have been trading on the AMEX, including the recent IPO of our subsidiary, Medicsight, which unlocked significant value for our shareholders. The value of both of our subsidiaries, Medicsight and Medicexchange, continue to rise and I believe that these investments, along with our strong cash position, remain undervalued by the investment community. That is why I have invested a further $5 million in buying an additional one million shares. We are poised to continue to execute on our growth plan, making strategic HCIT acquisitions that complement our expertise and experience, and continuing to develop our two subsidiaries. It is an honor to be part of this long-standing tradition and I am pleased for all the employees and shareholders of MGT to be able to ring the opening bell at the AMEX." About MGT Capital Investments, Inc. MGT Capital Investments is an investment company with two direct subsidiaries that focus solely on the dynamic and consolidating HCIT sector. The first subsidiary, Medicsight PLC, is a leading developer of computer-aided detection (CAD) and computer assisted reader (CAR) software solutions that are tested using one of the world's largest databases of verified CT scan data. Medicsight's CAD and CAR products help clinicians identify, measure, and analyze suspicious pathology, such as colorectal polyps and lung lesions. MGT Capital Investments has invested in and controls a second subsidiary, Medicexchange PLC, which operates Medicexchange.com, an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions for cardiac, thoracic, breast imaging, orthopedic, and gastro intestinal imaging. Medicexchange.com provides these solutions in a low-cost, on-demand and downloadable format, enhancing access to information and products for medical imaging professionals. Additional information can be found at All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission. Company contacts: For more information: MGT Capital Investments, Inc. Investors: Alex van Klaveren Stephanie Carrington / Zack Kubow 1410 Broadway +1 646-536-7017 / 7020 22nd Floor scarrington@theruthg New York, NY 10018 zkubow@theruthgroup. +1 646-257-2644 alex@mgtci.com |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
